Senate panel advances major drug prices bill

Published



A Senate panel advanced key legislation that would prevent brand name drug companies from blocking access to much cheaper generic drugs.

The Senate Judiciary Committee voted 16-5 on Thursday to advance the CREATES Act to the Senate floor. The bill would make it easier for generic drug makers to sue brand name drug makers that prevent access to samples of a product of which they want to make a cheaper generic version.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.